Nesset Endre 4

4 · GAN Ltd · Filed Dec 3, 2024

Form 4

Period: 2023-03-23

President, B2C

Transactions

Exercise/Conversion
Ordinary Shares
2024-11-29$0.01/sh+93,535$935→ 96,035 total
Award
Employee Stock Option (right to buy)
2023-03-23+2,000→ 2,000 total
Exercise: $0.01Exp: 2033-03-23→ Ordinary Shares (2,000 underlying)
Award
Employee Stock Option (right to buy)
2023-03-23+8,000→ 8,000 total
Exercise: $0.01Exp: 2033-03-23→ Ordinary Shares (8,000 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-29−18,386→ 9,194 total
Exercise: $0.01Exp: 2032-03-11→ Ordinary Shares (18,386 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-29−31,859→ 0 total
Exercise: $0.01Exp: 2032-03-11→ Ordinary Shares (31,859 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-29−43,290→ 47,055 total
Exercise: $0.01Exp: 2032-11-12→ Ordinary Shares (43,290 underlying)

Holdings

Footnotes (5)

[F1]The option was granted on March 23, 2023 and is fully vested.
[F2]The option was granted to the Reporting Person on March 23, 2023, and vested with respect to one-fourth of the shares on March 23, 2024; the remaining three-fourths of the shares will vest in equal monthly installments over the subsequent 36 months, subject to the reporting person's continued service.
[F3]The option was granted to the Reporting Person on March 11, 2022, and vested with respect to one-fourth of the shares on March 11, 2023; the remaining three-fourths of the shares will vest in equal monthly installments over the subsequent 36 months, subject to the reporting person's continued service.
[F4]The option was granted on March 11, 2022 and is fully vested.
[F5]The option was granted to the Reporting Person on November 12, 2022, and vested with respect to one-fourth of the shares on November 12, 2023; the remaining three-fourths of the shares will vest in equal monthly installments over the subsequent 36 months, subject to the reporting person's continued service.

Documents

1 file